Back
Merck KGaA Vs. Revolution Medicines, Inc. Industry Stock Comparison
Buy
57
MKGAF
Merck KGaA
Last Price:
$146.99
Seasonality Move:
-1.83%
Buy
64
RVMD
Revolution Medicines, Inc.
Last Price:
$118.94
Seasonality Move:
-1.63%
Buy
57
Merck KGaA (MKGAF)
is a Buy
Is Merck KGaA a Buy, Sell or Hold?
-
The current Merck KGaA [MKGAF] share price is $151.21. The Score for MKGAF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
MKGAF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Revolution Medicines, Inc. (RVMD)
is a Buy
Is Revolution Medicines, Inc. a Buy, Sell or Hold?
-
The current Revolution Medicines, Inc. [RVMD] share price is $107.39. The Score for RVMD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
RVMD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MKGAF Stock Price Chart
What is Merck KGaA's stock price today?
-
The Merck KGaA share price today is $151.21The current trend is moderately bullish and MKGAF is experiencing slight buying pressure.
RVMD Stock Price Chart
What is Revolution Medicines, Inc.'s stock price today?
-
The Revolution Medicines, Inc. share price today is $107.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVMD is experiencing slight buying pressure.
MKGAF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.17 | Buy |
| Relative Strength Index (14 RSI): | 59.21 | Buy |
| Chaikin Money Flow: | 93 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (139.25 - 147.79) | Buy |
| Bollinger Bands (100): | (128.32 - 141.88) | Buy |
RVMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.48 | Buy |
| Relative Strength Index (14 RSI): | 88.38 | Buy |
| Chaikin Money Flow: | 5950544 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.87 - 88.29) | Buy |
| Bollinger Bands (100): | (42.5 - 75.96) | Buy |
MKGAF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 147.38 | Buy |
| 20-day SMA: | 144.05 | Buy |
| 50-day SMA: | 138.34 | Buy |
| 200-day SMA: | 134.06 | Buy |
| 8-day EMA: | 147.97 | Buy |
| 20-day EMA: | 144.73 | Buy |
| 50-day EMA: | 138.93 | Buy |
| 200-day EMA: | 92.48 | Buy |
RVMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.89 | Buy |
| 20-day SMA: | 81.66 | Buy |
| 50-day SMA: | 73.85 | Buy |
| 200-day SMA: | 48.59 | Buy |
| 8-day EMA: | 89.67 | Buy |
| 20-day EMA: | 83.17 | Buy |
| 50-day EMA: | 74.2 | Buy |
| 200-day EMA: | 54.94 | Buy |
Merck KGaA Earnings Growth & MKGAF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Revolution Medicines, Inc. Earnings Growth & RVMD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and an increase next year of $0.59 per share.
Merck KGaA Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Revolution Medicines, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||